These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Prenatal Management of Pregnancies at Risk of Fetal Neonatal Alloimmune Thrombocytopenia (FNAIT): Scientific Impact Paper No. 61. Regan F, Lees CC, Jones B, Nicolaides KH, Wimalasundera RC, Mijovic A, Royal College of Obstetricians and Gynaecologists. BJOG; 2019 Sep; 126(10):e173-e185. PubMed ID: 30968555 [Abstract] [Full Text] [Related]
3. Postnatal treatment for children with fetal and neonatal alloimmune thrombocytopenia: a multicentre, retrospective, cohort study. de Vos TW, Winkelhorst D, Árnadóttir V, van der Bom JG, Canals Surís C, Caram-Deelder C, Deschmann E, Haysom HE, Hverven HBC, Lozar Krivec J, McQuilten ZK, Muñiz-Diaz E, Nogués N, Oepkes D, Porcelijn L, van der Schoot CE, Saxonhouse M, Sola-Visner M, Tiblad E, Tiller H, Wood EM, Young V, Železnik M, de Haas M, Lopriore E. Lancet Haematol; 2022 Nov; 9(11):e844-e853. PubMed ID: 36108655 [Abstract] [Full Text] [Related]
4. Postnatal management of fetal and neonatal alloimmune thrombocytopenia: the role of matched platelet transfusion and IVIG. te Pas AB, Lopriore E, van den Akker ES, Oepkes D, Kanhai HH, Brand A, Walther FJ. Eur J Pediatr; 2007 Oct; 166(10):1057-63. PubMed ID: 17177068 [Abstract] [Full Text] [Related]
5. Fetal and Neonatal Alloimmune Thrombocytopenia-New Prospects for Fetal Risk Assessment of HPA-1a-Negative Pregnant Women. Kjeldsen-Kragh J, Bengtsson J. Transfus Med Rev; 2020 Oct; 34(4):270-276. PubMed ID: 33039264 [Abstract] [Full Text] [Related]
6. Non-invasive risk-assessment and bleeding prophylaxis with IVIG in pregnant women with a history of fetal and neonatal alloimmune thrombocytopenia: management to minimize adverse events. Wienzek-Lischka S, Sawazki A, Ehrhardt H, Sachs UJ, Axt-Fliedner R, Bein G. Arch Gynecol Obstet; 2020 Aug; 302(2):355-363. PubMed ID: 32495019 [Abstract] [Full Text] [Related]
7. New developments in fetal and neonatal alloimmune thrombocytopenia. Bussel JB, Vander Haar EL, Berkowitz RL. Am J Obstet Gynecol; 2021 Aug; 225(2):120-127. PubMed ID: 33839095 [Abstract] [Full Text] [Related]
8. Fetal and neonatal alloimmune thrombocytopenia: recommendations for evidence-based practice, an international approach. Lieberman L, Greinacher A, Murphy MF, Bussel J, Bakchoul T, Corke S, Kjaer M, Kjeldsen-Kragh J, Bertrand G, Oepkes D, Baker JM, Hume H, Massey E, Kaplan C, Arnold DM, Baidya S, Ryan G, Savoia H, Landry D, Shehata N, International Collaboration for Transfusion Medicine Guidelines (ICTMG). Br J Haematol; 2019 May; 185(3):549-562. PubMed ID: 30828796 [Abstract] [Full Text] [Related]
9. [Thirty years of platelet immunology in fetal and neonatal alloimmune thrombocytopenia management, current situation]. Petermann R. Transfus Clin Biol; 2017 Sep; 24(3):166-171. PubMed ID: 28673503 [Abstract] [Full Text] [Related]
10. Clinical and laboratory predictors of fetal and neonatal alloimmune thrombocytopenia. Matusiak K, Patriquin CJ, Deniz S, Dzaja N, Smith JW, Wang G, Nazy I, Kelton JG, Arnold DM. Transfusion; 2022 Nov; 62(11):2213-2222. PubMed ID: 36239096 [Abstract] [Full Text] [Related]
11. Fetal and neonatal alloimmune thrombocytopenia: evidence based antenatal and postnatal management strategies. Winkelhorst D, Oepkes D, Lopriore E. Expert Rev Hematol; 2017 Aug; 10(8):729-737. PubMed ID: 28644735 [Abstract] [Full Text] [Related]
12. A review of the contemporary management of fetal and neonatal alloimmune thrombocytopenia in an Australian tertiary obstetric hospital. Cook TJ, Qiu CC, Dickinson JE. Aust N Z J Obstet Gynaecol; 2012 Aug; 52(4):321-6. PubMed ID: 22510050 [Abstract] [Full Text] [Related]
13. Epidemiology and management of fetal and neonatal alloimmune thrombocytopenia. de Vos TW, Winkelhorst D, de Haas M, Lopriore E, Oepkes D. Transfus Apher Sci; 2020 Feb; 59(1):102704. PubMed ID: 31974030 [Abstract] [Full Text] [Related]
14. Clinical characteristics of human platelet antigen (HPA)-1a and HPA-5b alloimmunised pregnancies and the association between platelet HPA-5b antibodies and symptomatic fetal neonatal alloimmune thrombocytopenia. de Vos TW, Porcelijn L, Hofstede-van Egmond S, Pajkrt E, Oepkes D, Lopriore E, van der Schoot CE, Winkelhorst D, de Haas M. Br J Haematol; 2021 Nov; 195(4):595-603. PubMed ID: 34402048 [Abstract] [Full Text] [Related]
16. [PREVFNAIT prevention of foetal/neonatal alloimmune thrombocytopenia (FNAIT) in Polish foetuses and newborns--the PREVFNAIT program]. Uhrynowska ME, Dębska M, Guz K, Orzińska A, Wróbel A, Maślanka K, Dębski R, Brojer E. Ginekol Pol; 2015 Jan; 86(1):62-6. PubMed ID: 25775877 [Abstract] [Full Text] [Related]
17. Screening in pregnancy for fetal or neonatal alloimmune thrombocytopenia: systematic review. Kamphuis MM, Paridaans N, Porcelijn L, De Haas M, Van Der Schoot CE, Brand A, Bonsel GJ, Oepkes D. BJOG; 2010 Oct; 117(11):1335-43. PubMed ID: 20618318 [Abstract] [Full Text] [Related]
18. Fetal/Neonatal Alloimmune Thrombocytopenia: Pathogenesis, Diagnostics and Prevention. Brojer E, Husebekk A, Dębska M, Uhrynowska M, Guz K, Orzińska A, Dębski R, Maślanka K. Arch Immunol Ther Exp (Warsz); 2016 Aug; 64(4):279-90. PubMed ID: 26564154 [Abstract] [Full Text] [Related]
19. Maternal HPA-1a antibody level and its role in predicting the severity of Fetal/Neonatal Alloimmune Thrombocytopenia: a systematic review. Kjaer M, Bertrand G, Bakchoul T, Massey E, Baker JM, Lieberman L, Tanael S, Greinacher A, Murphy MF, Arnold DM, Baidya S, Bussel J, Hume H, Kaplan C, Oepkes D, Ryan G, Savoia H, Shehata N, Kjeldsen-Kragh J, International Collaboration for Transfusion Medicine Guidelines. Vox Sang; 2019 Jan; 114(1):79-94. PubMed ID: 30565711 [Abstract] [Full Text] [Related]
20. Fetal and neonatal alloimmune thrombocytopenia. van den Akker ES, Oepkes D. Best Pract Res Clin Obstet Gynaecol; 2008 Feb; 22(1):3-14. PubMed ID: 17936686 [Abstract] [Full Text] [Related] Page: [Next] [New Search]